These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 35211017)

  • 1. Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect.
    Huang J; Wu R; Chen L; Yang Z; Yan D; Li M
    Front Pharmacol; 2022; 13():811406. PubMed ID: 35211017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside.
    Li Y; Lin R; Peng X; Wang X; Liu X; Li L; Bai R; Wen S; Ruan Y; Chang X; Tang R; Liu N
    Oxid Med Cell Longev; 2022; 2022():3659278. PubMed ID: 36187332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Aspects of Anthracycline Cardiotoxicity.
    Russo M; Della Sala A; Tocchetti CG; Porporato PE; Ghigo A
    Curr Treat Options Oncol; 2021 Feb; 22(2):18. PubMed ID: 33547494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
    Ghigo A; Li M; Hirsch E
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.
    Stěrba M; Popelová O; Vávrová A; Jirkovský E; Kovaříková P; Geršl V; Simůnek T
    Antioxid Redox Signal; 2013 Mar; 18(8):899-929. PubMed ID: 22794198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
    Murabito A; Hirsch E; Ghigo A
    Front Cardiovasc Med; 2020; 7():35. PubMed ID: 32226791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies.
    Wang T; Xing G; Fu T; Ma Y; Wang Q; Zhang S; Chang X; Tong Y
    Int J Med Sci; 2024; 21(5):809-816. PubMed ID: 38617011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal evaluation of oxidative stress - mitochondrial dysfunction - ferroptosis genes in anthracycline-induced cardiotoxicity.
    Qianqian R; Peng Z; Licai Z; Ruizhi Z; Tianhe Y; Xiangwen X; Chuansheng Z; Fan Y
    BMC Cardiovasc Disord; 2024 Jul; 24(1):350. PubMed ID: 38987722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging.
    Jong J; Pinney JR; Packard RRS
    Front Cardiovasc Med; 2022; 9():919719. PubMed ID: 35990941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthracycline-induced cardiotoxicity: An overview from cellular structural perspective.
    Li H; Wang M; Huang Y
    Biomed Pharmacother; 2024 Oct; 179():117312. PubMed ID: 39167843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine.
    Cheah IK; Tang RMY; Wang X; Sachaphibulkij K; Chong SY; Lim LHK; Wang JW; Halliwell B
    Antioxidants (Basel); 2023 Jan; 12(2):. PubMed ID: 36829879
    [No Abstract]   [Full Text] [Related]  

  • 12. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
    Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
    J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions.
    Osataphan N; Phrommintikul A; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2020 Jun; 24(12):6534-6557. PubMed ID: 32336039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline Cardiotoxicity: It Is Possible to Teach an Old Dog Some New Tricks.
    Alvarez-Cardona J; Lenihan DJ
    Cardiol Clin; 2019 Nov; 37(4):355-363. PubMed ID: 31587778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling Pathways Underlying Anthracycline Cardiotoxicity.
    Sala V; Della Sala A; Hirsch E; Ghigo A
    Antioxid Redox Signal; 2020 May; 32(15):1098-1114. PubMed ID: 31989842
    [No Abstract]   [Full Text] [Related]  

  • 16. The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity.
    Russo M; Bono E; Ghigo A
    Curr Heart Fail Rep; 2021 Aug; 18(4):180-190. PubMed ID: 34081265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
    He L; Liu F; Li J
    Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of iron in anthracycline cardiotoxicity.
    Gammella E; Maccarinelli F; Buratti P; Recalcati S; Cairo G
    Front Pharmacol; 2014; 5():25. PubMed ID: 24616701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation.
    Rocca C; Pasqua T; Cerra MC; Angelone T
    Antioxid Redox Signal; 2020 May; 32(15):1081-1097. PubMed ID: 31928066
    [No Abstract]   [Full Text] [Related]  

  • 20. Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?
    Dempke WCM; Zielinski R; Winkler C; Silberman S; Reuther S; Priebe W
    Eur J Cancer; 2023 May; 185():94-104. PubMed ID: 36966697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.